The future of medicine, maintaining an edge in biomedical innovation, and the cost of health care in America were among the topics explored by Mount Sinai Health System leaders during the 2014 Aspen Ideas Festival, a yearly conclave that attracts several thousand policy makers, innovators, entrepreneurs, and executives who participate in thought-provoking discussions on health care and other major issues that impact America.
Erik Lium, PhD, an expert in academic-industry partnerships and commercializing early-stage scientific discoveries, has joined the Mount Sinai Health System as Vice President and Executive Director of Mount Sinai Innovation Partners (MSIP). In this role, Dr. Lium leads MSIP’s efforts to foster collaborative partnerships with pharmaceutical, medical device, diagnostic, and information technology companies, and to commercialize Mount Sinai discoveries.
The Mount Sinai Health System recently established the Mount Sinai Institute of Technology (MSIT), with a $5 million grant from the New York City Economic Development Corporation (NYCEDC). As part of Icahn School of Medicine at Mount Sinai, MSIT will train students to develop technology-based solutions that improve human health, and serve as an incubator for transformative, cost-effective discoveries.